Cogent Biosciences, Inc. COGT Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s other income, net (note 6)?
- Cogent Biosciences, Inc. (COGT) reported other income, net (note 6) of -$140K in Q1 2026.
- How has Cogent Biosciences, Inc.'s other income, net (note 6) changed year-over-year?
- Cogent Biosciences, Inc.'s other income, net (note 6) decreased by 2700.0% year-over-year, from -$5K to -$140K.
- What is the long-term trend for Cogent Biosciences, Inc.'s other income, net (note 6)?
- Over 2 years (2023 to 2025), Cogent Biosciences, Inc.'s other income, net (note 6) has grown at a -85.5% compound annual growth rate (CAGR), from $950K to -$20K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.